Supplementary Table 1: Serum tumour markers of histological subtype12.
Supplement
Table 2: Univariate analysis.
Supplementary
Table 3: Characteristics of patients who progressed/recurred.
Supplementary Table 4: Characteristics of
all patients included in the study.
Funding
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No professional writing assistance was utilized in the production of this manuscript.